Patents Assigned to Verily Ufe Sciences LLC
  • Patent number: 11475988
    Abstract: Introduced here are diabetes management platforms able to impute blood glucose level values for a subject whose glycemic health state is being monitored. These imputed values can be used to estimate the glycemic health state of the subject at a given point in time, identify appropriate recommendations for improving the glycemic health state, etc. More specifically, a diabetes management platform can initially acquire one or more explicit data values generated by a glucose monitoring device. The diabetes management platform can then design a statistical model for imputing data values based on the one or more explicit data values. The diabetes management platform may employ several different computational techniques for performing imputation.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: October 18, 2022
    Assignee: Verily Ufe Sciences LLC
    Inventors: Joshua Burkart, Nathan Dickerson Beach